Zealand Pharma A/S | ZEAL - Ebitda


Zealand Pharma A/S reported -379M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -5.56M 4.13M Jun/2026
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Moderna USD -687M 571M Jun/2026
Organon & Co USD 502M 131M Sep/2026
Revvity USD 227.55M 629K Sep/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Tilray USD 8.36M 1.82M Sep/2025
Viatris USD 1.2B 7.4M Sep/2026
Xeris Pharmaceuticals USD -20.94M 33.27M Jun/2026
Zealand Pharma A/S -379M 348.47M Mar/2026